SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-207605
Filing Date
2021-07-02
Accepted
2021-07-02 16:09:41
Documents
19

Document Format Files

Seq Description Document Type Size
1 424B4 d104413d424b4.htm 424B4 1925787
2 GRAPHIC g104413g00q15.jpg GRAPHIC 177155
3 GRAPHIC g104413g03a03.jpg GRAPHIC 147367
4 GRAPHIC g104413g04q02.jpg GRAPHIC 138433
5 GRAPHIC g104413g11t00.jpg GRAPHIC 138632
6 GRAPHIC g104413g20a69.jpg GRAPHIC 81786
7 GRAPHIC g104413g21g20.jpg GRAPHIC 45080
8 GRAPHIC g104413g22y47.jpg GRAPHIC 64941
9 GRAPHIC g104413g30s55.jpg GRAPHIC 51058
10 GRAPHIC g104413g51i08.jpg GRAPHIC 106470
11 GRAPHIC g104413g52c34.jpg GRAPHIC 48150
12 GRAPHIC g104413g56t67.jpg GRAPHIC 84325
13 GRAPHIC g104413g64m48.jpg GRAPHIC 90608
14 GRAPHIC g104413g71z61.jpg GRAPHIC 52889
15 GRAPHIC g104413g82e41.jpg GRAPHIC 64605
16 GRAPHIC g104413g89k52.jpg GRAPHIC 88136
17 GRAPHIC g104413g89w33.jpg GRAPHIC 87529
18 GRAPHIC g104413g92p79.jpg GRAPHIC 201333
19 GRAPHIC g104413g98x03.jpg GRAPHIC 85803
  Complete submission text file 0001193125-21-207605.txt   4332459
Mailing Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551
Business Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-256945 | Film No.: 211070077
SIC: 2836 Biological Products, (No Diagnostic Substances)